Parabilis Medicines (PBLS) Financials: Revenue & Earnings

PBLS price $26.96 +0.45 +1.70%

Ticker
PBLS
Price
$26.96
Change
+0.45 +1.70%
Market cap ?
$3.29B
P/E ?
-0.73
Dividend yield ?
0.00%
Beta ?
5.03
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
63
Value
55
Quality
40
Growth
93

Stocklytics score rationale: value 55, quality 40, growth 93.

Financials

20242025
00

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.

Fair value

PBLS fair value Not meaningful. Price $26.96.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare PBLS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.40—375.00K
2026-08-13-2.32-0.17100.00K16.67M
2026-05-19-0.72———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-22Tendler CraigBuy20.29K$39.36798.77K
2026-08-22Tendler CraigOther16.25K$2.4239.31K
2026-07-22RA CAPITAL MANAGEMENT, L.P.Buy47.25K$29.771.41M
2026-07-21RA CAPITAL MANAGEMENT, L.P.Buy37.72K$30.001.13M
2026-07-21RA CAPITAL MANAGEMENT, L.P.Buy6.50K$29.17189.72K
2026-07-21RA CAPITAL MANAGEMENT, L.P.Buy21.70K$27.96606.62K
2026-07-20RA CAPITAL MANAGEMENT, L.P.Buy32.99K$27.72914.40K
2026-07-20RA CAPITAL MANAGEMENT, L.P.Buy98.43K$27.132.67M
2026-06-15SEBULSKY ALANBuy4.07K$27.10110.15K
2026-06-15SEBULSKY ALANBuy5.00K$26.00129.99K
2026-06-12SEBULSKY ALANBuy8.44K$27.67233.39K
2026-06-11Levy GuyBuy375.00K$20.007.50M
2026-06-11Levy GuyBuy125.00K$20.002.50M
2026-06-11Levy GuyBuy527.07K$9.485.00M
2026-06-11Levy GuySell527.07K$9.485.00M
2026-06-11RA CAPITAL MANAGEMENT, L.P.Buy19.73M$20.00394.57M
2026-06-11RA CAPITAL MANAGEMENT, L.P.Buy6.56M——
2026-06-11RA CAPITAL MANAGEMENT, L.P.Buy1.46M$20.0029.21M
2026-06-11RA CAPITAL MANAGEMENT, L.P.Buy1.19M——
2026-06-11RA CAPITAL MANAGEMENT, L.P.Sell160.56K——
2026-06-11RA CAPITAL MANAGEMENT, L.P.Sell1.67M——
2026-06-11FITZGERALD EDWARD MBuy5.27K——
2026-06-11FITZGERALD EDWARD MBuy3.88K——
2026-06-11FITZGERALD EDWARD MBuy5.54K——
2026-06-11FITZGERALD EDWARD MBuy5.33K——
2026-06-11FITZGERALD EDWARD MBuy3.67K——
2026-06-11FITZGERALD EDWARD MBuy8.11K——
2026-06-11SEBULSKY ALANBuy12.50K$20.00250.00K
2026-06-11Borisy AlexisBuy105.41K——
2026-06-11Borisy AlexisBuy162.22K——
2026-06-11Flynn James EBuy407.13K——
2026-06-11Flynn James EBuy260.99K——
2026-06-11Flynn James EBuy149.24K——
2026-06-11Flynn James EBuy122.99K——
2026-06-11Flynn James ESell464.55K——
2026-06-11Flynn James ESell166.07K——
2026-06-11Flynn James ESell143.65K——
2026-06-11Flynn James ESell246.73K——
2026-06-09Levy GuyOther527.07K$9.485.00M
2026-06-09RA CAPITAL MANAGEMENT, L.P.Buy20.21K$20.00404.30K
2026-06-09Borisy AlexisBuy20.21K$20.00404.30K
2026-06-09Weber BarbaraBuy20.21K$20.00404.30K
2026-06-09Yeshwant KrishnaBuy20.21K$20.00404.30K
2026-06-09FITZGERALD EDWARD MBuy20.21K$20.00404.30K
2026-06-09Simson JakeBuy20.21K$20.00404.30K
2026-06-09Klausner RichardBuy20.21K$20.00404.30K
2026-06-09SEBULSKY ALANBuy39.79K$20.00795.84K
2026-06-09RA CAPITAL MANAGEMENT, L.P.Other104.75K——
2026-06-09RA CAPITAL MANAGEMENT, L.P.Other1.08M——
2026-06-09Mammen MathaiOther2.38M$3.438.15M
2026-06-09Mammen MathaiOther590.94K$1.48874.59K
2026-06-09Mammen MathaiOther2.27M$3.147.14M
2026-06-09SEBULSKY ALANOther0——
2026-06-09Mhatre RohinOther181.95K$1.48269.28K
2026-06-09Mhatre RohinOther243.68K$3.14765.16K
2026-06-09Yeshwant KrishnaOther0——
2026-06-09Flynn James EOther122.99K——
2026-06-09Flynn James EOther149.24K——
2026-06-09Flynn James EOther260.99K——
2026-06-09Flynn James EOther407.13K——
2026-06-09Jurgensen TeresaOther214.44K$1.88403.14K
2026-06-09Jurgensen TeresaOther162.45K$3.14510.10K
2026-06-09Klausner RichardOther21.27K$4.6298.28K
2026-06-09Klausner RichardOther48.74K$1.8891.62K
2026-06-09Ho Helen Huei-inOther519.85K$4.092.13M
2026-06-09FITZGERALD EDWARD MOther16.25K$1.8530.05K
2026-06-09FITZGERALD EDWARD MOther16.25K$4.8278.30K
2026-06-09FITZGERALD EDWARD MOther32.49K$3.14102.02K
2026-06-09FITZGERALD EDWARD MOther5.54K——
2026-06-09FITZGERALD EDWARD MOther3.88K——
2026-06-09FITZGERALD EDWARD MOther5.27K——
2026-06-09Benzaghou Mohammed FawziOther357.40K$2.42864.90K
2026-06-09Benzaghou Mohammed FawziOther243.68K$3.14765.16K
2026-06-09Simson JakeOther0——
2026-06-09Borisy AlexisOther105.41K——
2026-06-09Kotarakos Thomas RodolphoOther48.74K$4.82234.91K
2026-06-09Kotarakos Thomas RodolphoOther165.70K$1.48245.24K
2026-06-09Kotarakos Thomas RodolphoOther292.42K$3.14918.19K
2026-06-09Weber BarbaraOther2.60K$1.854.81K
2026-06-09Weber BarbaraOther13.65K$4.6263.04K
2026-06-09Weber BarbaraOther16.25K$4.8278.30K
2026-06-09Weber BarbaraOther32.49K$3.14102.02K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 80. Ownership 342.35%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.28.93MNewNew791.91M
FMR LLC10.29MNewNew281.71M
ARCH VENTURE MANAGEMENT, LLC6.41MNewNew175.52M
VENBIO PARTNERS LLC5.27MNewNew144.15M
ALPHABET INC.4.92MNewNew134.65M
NEXTECH INVEST LTD.4.66MNewNew127.63M
CORMORANT ASSET MANAGEMENT, LP4.62MNewNew126.33M
REGENERON PHARMACEUTICALS, INC.4.17MNewNew114.04M
SIREN, L.L.C.2.99MNewNew81.90M
FARALLON CAPITAL MANAGEMENT, L.L.C.2.37MNewNew64.82M
JUPITER TOPCO LLC2.30MNewNew62.71M
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.1.92MNewNew52.57M
DEERFIELD MANAGEMENT COMPANY, L.P.1.88MNewNew51.47M
GENERAL CATALYST GROUP MANAGEMENT, LLC1.60MNewNew43.82M
GENERAL ATLANTIC, L.P.1.54MNewNew42.11M
SOLEUS CAPITAL MANAGEMENT, L.P.1.47MNewNew40.10M
VANGUARD PORTFOLIO MANAGEMENT LLC1.30MNewNew35.65M
VANGUARD CAPITAL MANAGEMENT LLC1.16MNewNew31.67M
JPMORGAN CHASE & CO1.04MNewNew30.44M
FORESITE CAPITAL MANAGEMENT VI LLC999.04KNewNew27.34M
CATALIO CAPITAL MANAGEMENT, LP824.04KNewNew22.55M
ALLIANCEBERNSTEIN L.P.810.28KNewNew22.18M
PRICE T ROWE ASSOCIATES INC /MD/751.95KNewNew20.58M
CASDIN CAPITAL, LLC645.69KNewNew17.67M
VENROCK ADVISER, LLC625.00KNewNew17.11M

Earnings and financials

Parabilis Medicines, Inc. (PBLS) trades at $26.96, with a market cap of $3.29B and a trailing P/E of -0.73. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

20242025
00

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Parabilis Medicines (PBLS) Financials: Revenue & Earnings

PBLS$26.96+0.45 +1.70%

$3.29B

Market Cap

-0.73

P/E

—

Forward P/E

63

Score

Price History